Triple-Pathway Fat Loss. Maximum Metabolic Power.
🔬 Product Overview
Retatrutide is a cutting-edge triple hormone receptor agonist that simultaneously targets GLP-1, GIP, and glucagon receptors. This multifaceted approach offers unparalleled potential in weight loss and metabolic health research.
🚀 Key Benefits
Triple Hormone Activation: Engages GLP-1, GIP, and glucagon receptors to synergistically enhance weight loss and metabolic regulation.
Superior Weight Reduction: In a 48-week phase 2 study, participants experienced up to 24.2% body weight loss with 12 mg dosing, surpassing results from other treatments like Ozempic and Mounjaro citeturn0search0.
Enhanced Metabolic Health: Demonstrated improvements in liver fat content and cardiometabolic markers, indicating broader health benefits citeturn0search11.
Reduced Dosing Frequency: Due to its potency, one vial will last for 5+weeks, depending on the research protocol.
🧪 Composition
Active Ingredient: Retatrutide
Concentration: 10mg per vial
Form: Lyophilized peptide powder
📦 Usage & Storage
Intended Use: For research purposes only
Storage: Store lyophilized powder in a cool, dry place. After reconstitution, refrigerate at 2–8°C and use within the designated study period.
🧠 Why Retatrutide Stands Out
More Effective: Achieves greater weight loss in a shorter time frame compared to GLP-1 mono-agonists and dual agonists.
Comprehensive Approach: Addresses multiple pathways involved in weight regulation and metabolic health.
Research-Backed: Supported by robust clinical data demonstrating its efficacy and potential benefits citeturn0search0.
🔥 Pioneering the Future of Weight Loss Research
Retatrutide represents a significant advancement in the field of metabolic research. Its unique triple-action mechanism offers a promising avenue for studies focused on obesity, type 2 diabetes, and related metabolic disorders.
🛒 Order your 10mg Retatrutide today for £200.00
